Brind.

Aristotle Atlantic highlighted Bio-Techne in its investor letter, preferring certain AI stocks over the company.

1 report, 1 independent Updated Aug 1

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Bio-Techne

Keep exploring

The entities involved

Bio-Techne
company
- Bio-Techne has entered a strategic partnership with Spear Bio to distribute its immunoassays, advancing therapeutic development.Sun 13:32
- Trump pledged to unleash American oil and gas, involving MBX Biosciences, Inc.Sun 05:01

Coverage

Newest first; wire copies grouped

Aug 1Insider MonkeyBio-Techne Corporation (TECH) Slid on Rise in Investors’ Concerns Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” second quarter 2025 investor letter